Logo image of HBIO

HARVARD BIOSCIENCE INC (HBIO) Stock Earnings & Estimates

NASDAQ:HBIO - US4169061052 - Common Stock

0.5202 USD
-0.01 (-2.6%)
Last: 8/28/2025, 6:18:39 PM
0.5131 USD
-0.01 (-1.36%)
After Hours: 8/28/2025, 6:18:39 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
HBIO revenue by date.HBIO revenue by date.
113.3M
-4.71%
112.25M
-0.93%
94.135M
-16.14%
87.21M
-7.36%
93.432M
7.13%
EBITDA
YoY % growth
HBIO ebitda by date.HBIO ebitda by date.
2.87M
-73.96%
9.283M
223.45%
1.781M
-80.81%
7.395M
315.22%
13.821M
86.90%
EBIT
YoY % growth
HBIO ebit by date.HBIO ebit by date.
-4.7M
-238.24%
2.285M
148.62%
-5.376M
-335.27%
-25.653M
-377.18%
918K
103.58%
Operating Margin
HBIO operating margin by date.HBIO operating margin by date.
-4.15%2.04%-5.71%-29.42%0.98%
EPS
YoY % growth
HBIO eps by date.HBIO eps by date.
0.12
-52.00%
0.15
25.00%
0.06
-60.00%
0.03
-57.50%
0.10
280.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.01
125.50%
0.05
-23.50%
-0.01
-2.00%
0.02
304.00%
-0.01
-300.00%
0.04
-11.11%
Revenue
Q2Q % growth
20.655M
-5.99%
24.021M
-2.18%
22.134M
1.65%
24.174M
18.21%
24.174M
17.04%
27.234M
13.38%
EBITDA
Q2Q % growth
2.244M
-39.38%
4.335M
-41.30%
1.632M
5,164.52%
3.57M
43.84%
3.366M
50.00%
5.202M
20.00%
EBIT
Q2Q % growth

100.00%
2.142M
839.47%
-1.122M
30.91%
816K
203.42%
612K2.448M
14.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.01 -0.010.001.96%
Q1 2025
Q2Q % growth
-0.01
-150.00%
-0.040.0375.49%
Q4 2024
Q2Q % growth
0.06
50.00%
0.050.0117.65%
Q3 2024
Q2Q % growth
-0.02
-300.00%
0.03-0.05-173.52%
Q2 2024
Q2Q % growth
0.00
-100.00%
0.05-0.05-100.00%
Q1 2024
Q2Q % growth
0.02
-66.67%
0.020.00-15.95%
Q4 2023
Q2Q % growth
0.04 0.05-0.01-21.57%
Q3 2023
Q2Q % growth
0.01
200.00%
0.04-0.03-75.49%
Q2 2023
Q2Q % growth
0.04
-20.00%
0.06-0.02-38.08%
Q1 2023
Q2Q % growth
0.06
50.00%
0.050.0117.65%
Q4 2022
Q2Q % growth
0.04
-50.00%
0.030.0117.66%
Q3 2022
Q2Q % growth
-0.01
-116.67%
0.07-0.08-114.71%
Q2 2022
Q2Q % growth
0.05
-16.67%
0.06-0.01-18.30%
Q1 2022
Q2Q % growth
0.04
-20.00%
0.05-0.01-26.47%
Q4 2021
Q2Q % growth
0.08 0.10-0.02-21.57%
Q3 2021
Q2Q % growth
0.06
50.00%
0.060.00-1.96%
Q2 2021
Q2Q % growth
0.06
20.00%
0.060.00-7.12%
Q1 2021
Q2Q % growth
0.05
600.00%
0.030.0247.07%
Q4 2020
Q2Q % growth
0.08 0.070.0120.66%
Q3 2020
Q2Q % growth
0.04 0.040.0012.04%
Q2 2020
Q2Q % growth
0.05
25.00%
-0.010.06590.20%
Q1 2020
Q2Q % growth
-0.01
-150.00%
0.03-0.04-129.41%
Q4 2019
Q2Q % growth
0.08 0.09-0.01-9.51%
Q3 2019
Q2Q % growth
0.04 0.05-0.01-26.47%
Q2 2019
Q2Q % growth
0.04 0.040.00-1.96%
Q1 2019
Q2Q % growth
0.02 0.03-0.01-41.17%
HBIO Yearly EPS VS EstimatesHBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
20.45M
-11.46%
20.808M-358K-1.72%
Q1 2025
Q2Q % growth
21.774M
-11.17%
19.584M2.19M11.18%
Q4 2024
Q2Q % growth
24.556M
-12.78%
24.633M-77K-0.31%
Q3 2024
Q2Q % growth
21.97M
-13.38%
25.806M-3.836M-14.86%
Q2 2024
Q2Q % growth
23.097M
-19.69%
26.928M-3.831M-14.23%
Q1 2024
Q2Q % growth
24.512M
-18.24%
26.309M-1.797M-6.83%
Q4 2023
Q2Q % growth
28.153M
-0.97%
29.692M-1.539M-5.18%
Q3 2023
Q2Q % growth
25.363M
-5.78%
28.584M-3.221M-11.27%
Q2 2023
Q2Q % growth
28.759M
-1.54%
30.24M-1.481M-4.90%
Q1 2023
Q2Q % growth
29.98M
4.17%
29.424M556K1.89%
Q4 2022
Q2Q % growth
28.43M
-14.00%
30.94M-2.51M-8.11%
Q3 2022
Q2Q % growth
26.92M
-9.24%
29.468M-2.548M-8.65%
Q2 2022
Q2Q % growth
29.21M
0.03%
31.096M-1.886M-6.07%
Q1 2022
Q2Q % growth
28.78M
6.63%
29.345M-565K-1.93%
Q4 2021
Q2Q % growth
33.06M
6.71%
33.622M-562K-1.67%
Q3 2021
Q2Q % growth
29.66M
23.38%
28.468M1.192M4.19%
Q2 2021
Q2Q % growth
29.2M
25.27%
28.221M979K3.47%
Q1 2021
Q2Q % growth
26.99M
13.55%
26.245M745K2.84%
Q4 2020
Q2Q % growth
30.98M
0.03%
27.676M3.304M11.94%
Q3 2020
Q2Q % growth
24.04M
-12.33%
24.536M-496K-2.02%
Q2 2020
Q2Q % growth
23.31M
-21.20%
22.639M671K2.96%
Q1 2020
Q2Q % growth
23.77M
-15.71%
28.431M-4.661M-16.39%
Q4 2019
Q2Q % growth
30.97M 32.436M-1.466M-4.52%
Q3 2019
Q2Q % growth
27.42M 29.243M-1.823M-6.23%
Q2 2019
Q2Q % growth
29.58M 29.58M0.00%
Q1 2019
Q2Q % growth
28.2M 28.934M-734K-2.54%
HBIO Yearly Revenue VS EstimatesHBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-50% -75% -50% -44.44%
Revenue-6.9% -17.01% -1.89% -1.89%